BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20071304)

  • 1. [Developments in cancer care with innovative genomics. 2008 report of the National Cancer Consortium].
    Tímár J; Kásler M; Heringh A; Soós M; Mathiász D; Romány A; Józsa A; Szilák L; Forrai T; Patthy L; Kovács G
    Magy Onkol; 2009 Dec; 53(4):321-34. PubMed ID: 20071304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Developments in cancer management by innovative genomics. 2006 report of the National Cancer Consortium].
    Tímár J; Kásler M; Kátai J; Soós M; Mathiasz D; Romány A; Patthy L; Kovács G; Józsa A; Szilák L; Forrai T
    Magy Onkol; 2006; 50(4):349-59. PubMed ID: 17216011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gene expression profiles in the diagnosis and prognosis of cancer].
    Kopper L; Tímár J
    Magy Onkol; 2002; 46(1):3-9. PubMed ID: 12050676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the human genome in cancer with genomic approaches.
    Scheel JR; Kuo MD
    J Vasc Interv Radiol; 2006 Aug; 17(8):1225-33. PubMed ID: 16923971
    [No Abstract]   [Full Text] [Related]  

  • 5. [Report on the first year of the activity of the National Oncological RD Consortium].
    Tímár J
    Magy Onkol; 2002; 46(4):297-300. PubMed ID: 12563351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Stemness" genomics law governs clinical behavior of human cancer: implications for decision making in disease management.
    Glinsky GV
    J Clin Oncol; 2008 Jun; 26(17):2846-53. PubMed ID: 18539963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hereditary cancer in adults.
    Lynch HT; Fusaro RM; Lynch J
    Cancer Detect Prev; 1995; 19(3):219-33. PubMed ID: 7750110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Activity of the National Oncology R&D Consortium in 2004].
    Tímár J;
    Magy Onkol; 2005; 49(1):3-7. PubMed ID: 15902326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic molecular classification of breast cancers based on gene expression profiling].
    Feng YM; Li XQ; Sun BC; Gao XC; Gu L; Niu Y; Hao XS
    Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):900-6. PubMed ID: 17533740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular oncology--perspectives in lung cancer.
    Huber RM; Stratakis DF
    Lung Cancer; 2004 Aug; 45 Suppl 2():S209-13. PubMed ID: 15552801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicine: profile of a tumour.
    Kallioniemi O
    Nature; 2004 Mar; 428(6981):379-82. PubMed ID: 15042074
    [No Abstract]   [Full Text] [Related]  

  • 12. Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet?
    Correa Geyer F; Reis-Filho JS
    Int J Surg Pathol; 2009 Aug; 17(4):285-302. PubMed ID: 19103611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling and clinical outcome in melanoma: in search of novel prognostic factors.
    Winnepenninckx V; van den Oord JJ
    Expert Rev Anticancer Ther; 2007 Nov; 7(11):1611-31. PubMed ID: 18020928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic strategies for personalized cancer therapy.
    Garman KS; Nevins JR; Potti A
    Hum Mol Genet; 2007 Oct; 16 Spec No. 2():R226-32. PubMed ID: 17911165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic applications of gene expression signatures in breast cancer.
    Normanno N; De Luca A; Carotenuto P; Lamura L; Oliva I; D'Alessio A
    Oncology; 2009; 77 Suppl 1():2-8. PubMed ID: 20130425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New generation of molecular prognostic and predictive tests for breast cancer.
    Pusztai L; Cristofanilli M; Paik S
    Semin Oncol; 2007 Apr; 34(2 Suppl 3):S10-6. PubMed ID: 17512431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial risk of cancer shortly after diagnosis of the first familial tumor.
    Bermejo JL; Hemminki K
    J Natl Cancer Inst; 2005 Nov; 97(21):1575-9. PubMed ID: 16264177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenomics in breast cancer: current trends and future directions.
    Wajapeyee N; Somasundaram K
    Curr Opin Mol Ther; 2004 Jun; 6(3):296-301. PubMed ID: 15264432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecule based diagnosis].
    Akaza H; Ichikawa T; Tsuruo T; Shimada Y; Moriwaki H; Mori M; Noguchi S; Nakamura S; Saijo N; Sone S; Isonishi S; Ohashi Y; Hinotsu S; von Euler M; Blackedge G
    Gan To Kagaku Ryoho; 2004 Jan; 31(1):125-33. PubMed ID: 14750337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pathologist's perspective on emerging genomic tests for breast cancer.
    Symmans WF
    Semin Oncol; 2007 Apr; 34(2 Suppl 3):S4-9. PubMed ID: 17512433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.